Learn, network, create, and nourish scientific collaborations at the hybrid International Society for Molecular NeuroDegeneration (ISMND) conference. Registration Open. Abstract submission deadline: July 15th, 2022
The original article was published in Molecular Neurodegeneration 2022 17:63
The Research article to this article has been published in Molecular Neurodegeneration 2021 16:48
The Letter to the Editor to this article has been published in Molecular Neurodegeneration 2022 17:64
The original article was published in Molecular Neurodegeneration 2021 16:48
Molecular Neurodegeneration presents a new thematic series, collating reviews which present and evaluate the challenges for the next decade of research into Alzheimer's disease.
Edited by Guojun Bu, Alison Goate and Todd Golde, reviews will continue to publish throughout 2021. The collection can be read here.
04 October 2022
04 October 2022
01 October 2022
The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
Citation Impact
18.879 - 2-year Impact Factor (2021)
15.024 - 5-year Impact Factor (2021)
2.702 - Source Normalized Impact per Paper (SNIP)
4.731 - SCImago Journal Rank (SJR)
Speed
20 days to first decision for all manuscripts (Median)
54 days to first decision for reviewed manuscripts only (Median)
Usage
1,034,660 downloads (2021)
1,462 Altmetric mentions (2021)
Molecular Neurodegeneration